Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based anticancer therapy: Tumor suppressor MiRNA-218 suppresses the expression L1CAM via down regulation of their target genes, 15/February/20145, 22.04, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that tumor suppressor MiRNAs-218, by decreasing the expression of their target gene, it may inhibit the expression of L1CAM. Thereby, it may inhibit the migration and invasion of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-218 activators” can be used to inhibit metastatic human tumors.
Amount: $ 300*
Undisclosed information: How MiRNA-218 suppresses the expression of L1CAM.
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation